In this podcast episode, Co-Hosts Tom Salemi and Chris Newmarker review how the medtech industry is handing the current shrinking job market. They’ll review this week’s Newmarker’s Newsmakers which includes Medtronic, Biosense Webster, Johnson & Johnson and high profile clinical meetings. Tom then interviews Mike Dineen, CEO of Tioga Cardiovascular, which is pushing the limits for heart valves. Tioga emerged from the prolific Shifamed incubator. Dineen gives history on both Shifamed and Tioga. To learn more about the FTC’s review of non-competes go here. https://www.ftc.gov/news-events/news/press-releases/2023/03/ftc-extends-public-comment-period-its-proposed-rule-ban-noncompete-clauses-until-april-19 Thanks for listening to the DeviceTalks Weekly Podcast.

In this episode, Annie Heath, Stryker’s vice president of diversity, equity and inclusion, explains how an interest in sales brought her to Stryker where she held positions in operations for most of her career. Heath also shares how her personal story inspired her to pursue a role leading Stryker’s DEI effort. In addition to building a more diverse workforce, Stryker is also collaborating with suppliers, clinical societies and other partners to create an environment where everyone feels included. This episode is sponsored by AcuityMD. Thanks for listening to StrykerTalks. Follow the DeviceTalks Podcast Network on any major podcast player to find additional episodes.

Medtech layoffs continue to mount. We’ll use this episode to begin to explore external and internal challenges. Looking externally, longtime industry watcher Henry Soch, now an executive-in-residence at Matter, shares his concerns about the current and future ability of medical device companies – both big and small – getting new technologies into hospitals. You can read Soch’s blog post here. https://healtech.blog/2022/12/28/health-care-disruptors-to-watch-in-2023/ Then, Joe Mullings, CEO of the Mullings Group, brings us inside his conversations with senior leaders of the medical device industry. In this interview, a sober Mullings reviews some of the mistakes large strategics have made. The result may be a few months of layoffs and cost-cutting. Mullings says companies could help themselves and the industry by not requiring their terminated employees to sign non-compete agreements. Mullings ends with some hopeful signs for medtech and useful tips for people looking to protect their careers. Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to this podcast on any major podcast application.

In this week’s episode, we’ll hear pitches from the 10 start-ups that have been selected as finalists for Medtech Color’s Pitch Competition. BIOMED – Bobby Ntoya IllumifyDx - Maria Navas-Moreno JuneBrain – Samantha Scott Level 42 AI – Shash Jumbe Movement Interactive – Eric Luster Navigate Maternity – Ariana McGee Oben Health – Peter Njongwe Tanzen Medical – Nilanjan Banerjee, Justin Brooks Thermaband – Debbie Dickinson, Markea Dickinson-Frazier Youme Healthcare – Hafeezah Muhammad Medtech Color Executive Director Kwame Ulmer joins Host Tom Salemi and Mass Device Associate Editor Sean Whooley on this week’s Newmarkers Newsmakers. This week’s list includes Johnson & Johnson, Origami Surgical, Asensus Surgical, Medtronic, AliveCor, and Apple. We also discuss the pitch contest, Medtech Color’s history, and an assessment of how effective the industry has been in increasing diversity of leadership in recent years. Thanks for listening to the DeviceTalks Weekly Podcast. You can listen to episodes of DeviceTalks podcasts on any major podcast player.

Wow, I think we have a cool new format for the podcast! This was a fun one! Holly Scott, vice president and senior partner of the Mullings Group, an executive search firm, shared her industry expertise and insights during Chris Newmarker’s Newsmakers. We covered a lot of ground there while reviewing news from Baxter, Medtronic, Titan Medical, Apple, as well as the many companies that reported layoffs over the coming week. Related topics centered around the waning lure of Working From Home, the move from tech to medtech, and what we have to do to build your own brand. We then examine the current layoff environment. While the situation may not be as bad as it seems on a macrolevel, every layoff brings some disruption to individual workers and families. Expert Coach Holly Scott offers some valuable advice for those who are looking to rebound from receiving a pink slip. She's got Five Steps! Thanks for listening to the DeviceTalks Weekly Podcast. You can listen to this podcast on any major podcast player.

The weekend ended with a bang as Abbott and Globus Medical both announced significant deals. Abbott picked up publicly traded Cardiovascular Solutions for $890 million while Globus Medical acquired – or merged if you prefer – with publicly held spine competitor NuVasive in a deal valued more than $3 billion. In this week’s episode, host Tom Salemi explores each deal with Wall Street Analysts Mike Matson and David Saxon from Needham. The conversation begins with the big question – Is this this start of a robust year for M&A. Executive Editor Chris Newmarker also delivers his Newmarker’s Newsmakers. Abbott, CSI, Globus, and NuVasive top the list along with GE Healthcare’s acquisition of Caption Health. Other medtech companies making the vaunted list include 3M, Dexcom, Ethicon, and Inspire Medical. This episode is sponsored by DeviceTalks Boston. Go to DeviceTalks.com to find out more information about our upcoming in-person conference. Thanks for listening to this episode of DeviceTalks Weekly. You can subscribe this podcast on any major podcast player.

Murthy Simhambhatla launched his medtech career during the epic race to develop groundbreaking drug-eluting stent technologies as a new approach to battling cardiovascular disease. Over two decades later, following a career that took him across the globe and clinical specialities, Simhambhatla finds himself involved in another exciting push to bring new technologies to bear on prevalent medical problems. Simhambhatla leads Setpoint Medical, a trail blazer in the neurostimulation space that’s tapping the vagus nerve as way to battle inflammation. In this discussion, we’ll cover Simhambhatla’s career and how Setpoint is positioned for the future following a significant capital raise. Chris Newmarker, executive editor of life sciences at MassDevice shares his Newmarker’s Newsmakers including Avonics, Invacare, Philips, Johnson & Johnson, 3M, Stryker, Edwards, Hologic, BD, Edwards, and Boston Scientific. Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast player.

Robert Cohen has his eyes on the future of orthopedic surgery, but he brings a wealth of knowledge about its past as well. In this interview, Cohen reviews his long history in orthopedic surgery, dating back to his studies in college. Over his career, Cohen has had a role in materials, 3D-printing, and began working with MAKO Surgical several years before its acquisition by Stryker in 2013. Now Cohen leads the team that will guide Stryker’s digital strategy in the future. Cohen, who chairs the board of the New Jersey Institute of Technology, wraps up the discussion sharing his thoughts about the future of engineering education. This episode is sponsored by Viant. Go to ViantMedical.com to learn more. Thanks for listening to the StrykerTalks Podcast. You can subscribe to the DeviceTalks Podcast Network on any major Podcast Player.

In this week’s episode, CEO Kevin Sayer takes a few minutes to share Dexcom’s vision for the future OUTSIDE of diabetes. What does this mean for people with diabetes and others who could benefit from the powerful Dexcom G7? We also bring in a very popular interview from our MedtronicTalks podcast series – Skip Kiil, president of cranial and spinal technologies, shares some very wise career advice that helped him accelerate his career. He also talks with Tom Salemi about his move to Medtronic and how the company is ramping up to dominate the spinal and cranial spaces. His interview is sponsored by Allied Motion Technologies. Chris Newmarker, executive editor of life sciences at MassDevice shares his Newmarker’s Newsmakers including Dexcom, Medtronic, Masimo, Philips, Abbott and Shockwave. Thanks for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network on any major podcast player.

Pristine Surgical CEO Bryan Lord spent his career advising and investing in medical device companies, so he didn’t immediately see how a “conspicuous outsider” like himself would be the right person to serve as CEO of start-up Pristine Surgical. But he immediately recognized the satisfaction in leading the company’s work to create first-of-its-kind 4K single-use surgical arthroscope designed for arthroscopic procedures. After securing 510(k) notification from the FDA, Pristine Surgical is ready to compete in the rigid endoscope market serving orthopedics and general surgery. Lord explains how Pristine can lower costs and improve efficiencies with the new tech and sales model. He also explains how Pristine expects to compete in the much larger flexible endoscope market. Chris Newmarker, executive editor of MassDevice, returns with his Newmarker’s Newsmakers featuring Verily, Medtronic, Sterigenics, CardiacSense, Masimo, and Philips. Our DeviceTalks Weekly Fastball returns with a pitch from FluidIQ. And to hear the entire interview with Steve Oesterle, go here. https://www.devicetalks.com/can-moon-surgical-fill-critical-role-in-the-or-analyst-matsons-take-on-jj-medtronic-and-more/ Thank you for listening to DeviceTalks Weekly. You can subscribe to the podcast on any major podcast application.